17-LUN-103-TS(3000-02-001) Niraparib Administered Alone & in Combination with Pembrolizumab in NSCLC

Grants and Contracts Details

StatusFinished
Effective start/end date3/20/18 → 10/30/18

Funding

  • Tesaro Incorporated: $22,134.00